Back to User profile » Dr Zengwu Shao
Papers published by Dr Zengwu Shao:
Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma
Hu H, Deng X, Song Q, Lv H, Chen W, Xing X, Zhu J, Tan Z, Cheng X, Wang B, Shao Z, Zhang Y
OncoTargets and Therapy 2020, 13:12673-12681
Published Date: 9 December 2020
The Personalized Shoulder Reconstruction Assisted by 3D Printing Technology After Resection of the Proximal Humerus Tumours
Hu H, Liu W, Zeng Q, Wang S, Zhang Z, Liu J, Zhang Y, Shao Z, Wang B
Cancer Management and Research 2019, 11:10665-10673
Published Date: 23 December 2019
Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway
Hu H, Wang S, Shi D, Zhong B, Huang X, Shi C, Shao Z
OncoTargets and Therapy 2019, 12:5377-5388
Published Date: 8 July 2019
Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis
Hu B, Shi D, Lv X, Wu F, Chen S, Shao Z
OncoTargets and Therapy 2018, 11:5083-5092
Published Date: 22 August 2018
Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
Hu B, Lv X, Gao F, Chen S, Wang S, Qing X, Liu J, Wang B, Shao Z
OncoTargets and Therapy 2017, 10:4379-4391
Published Date: 8 September 2017